ISIN | LU1849504649 |
---|---|
Valor Number | 42469455 |
Bloomberg Global ID | |
Fund Name | Protea Fund-Sectoral Healthcare Opportunities Fund I EUR |
Fund Provider |
Sectoral Asset Management Inc
1010 Sherbrooke St. West, Suite 1610 QC H3A 2R7 Montreal Canada Phone: +1 514 849 8777 E-Mail: BusinessDevelopment@sectoral.com |
Fund Provider | Sectoral Asset Management Inc |
Representative in Switzerland |
FundPartner Solutions (Suisse) SA Genève 75 |
Distributor(s) | |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The Sub-Fund’s investment objective is long-term growth of capital in USD. In order to achieve this objective, the Sub-Fund invests, while respecting the principle of risk diversification, primarily in equities (including, but not limited to, common stocks, preferred stocks, or other securities convertible into common stock) equity-like transferable securities, depositary receipts such as American Depositary Receipts (ADRs), Global Depositary Receipts (GDRs) and European Depositary Receipts (EDRs), participation certificates etc. of small, mid and large cap issuers, located worldwide, in the following healthcare sectors: Healthcare Equipment and Services, Pharmaceuticals, Biotechnology and Lifesciences. |
Peculiarities |
Current Price * | 366.80 EUR | 30.05.2025 |
---|---|---|
Previous Price * | 364.94 EUR | 28.05.2025 |
52 Week High * | 453.47 EUR | 18.10.2024 |
52 Week Low * | 358.61 EUR | 14.05.2025 |
NAV * | 366.80 EUR | 30.05.2025 |
Issue Price * | 366.80 EUR | 30.05.2025 |
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 67,335,869 | |
Unit/Share Assets *** | 680,648 | |
Trading Information SIX |
YTD Performance | -12.42% |
31.12.2024 - 30.05.2025
31.12.2024 30.05.2025 |
---|---|---|
YTD Performance (in CHF) | -13.05% |
31.12.2024 - 30.05.2025
31.12.2024 30.05.2025 |
1 month | -3.71% |
30.04.2025 - 30.05.2025
30.04.2025 30.05.2025 |
3 months | -17.39% |
28.02.2025 - 30.05.2025
28.02.2025 30.05.2025 |
6 months | -17.36% |
02.12.2024 - 30.05.2025
02.12.2024 30.05.2025 |
1 year | -11.12% |
30.05.2024 - 30.05.2025
30.05.2024 30.05.2025 |
2 years | -10.39% |
30.05.2023 - 30.05.2025
30.05.2023 30.05.2025 |
3 years | -5.19% |
31.05.2022 - 30.05.2025
31.05.2022 30.05.2025 |
5 years | +17.12% |
02.06.2020 - 30.05.2025
02.06.2020 30.05.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Eli Lilly and Co | 11.18% | |
---|---|---|
UnitedHealth Group Inc | 6.85% | |
Johnson & Johnson | 3.94% | |
AstraZeneca PLC | 3.89% | |
AbbVie Inc | 3.77% | |
Intuitive Surgical Inc | 3.20% | |
Abbott Laboratories | 3.19% | |
Boston Scientific Corp | 2.84% | |
Novo Nordisk AS Class B | 2.77% | |
Danaher Corp | 2.75% | |
Last data update | 30.04.2025 |
TER | 0.95% |
---|---|
TER date | 30.06.2023 |
Performance Fee *** | 20.00% |
PTR | |
Max. Management Fee *** | 0.60% |
Ongoing Charges *** | 0.95% |
SRRI ***
|
|
SRRI date *** | 30.04.2025 |